U
Better Therapeutics, Inc. BTTX
$0.0002 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Valuation
BTTX
Low
2-Year Historical Range
BTTX
Average
High
Market Cap
10.90K
< 10.90K
> 19.19M
Enterprise Value
7.72M
7.58M
> 40.00M
Price/Earnings (TTM)
0.000
-0.867
0.000
Earnings Per Share Growth (TTM)
-40.97%
-47.70%
-26.33%
Price/Earnings To Growth (TTM)
--
--
--
Price/Sales (TTM)
--
8.06
10.94
Price/Book (Q)
0.00
< -10.00
> 0.00
Enterprise Value/Revenue (TTM)
--
1,056.98
1,082.88
Enterprise Value/EBITDA (TTM)
-0.28
-1.33
-0.09
Enterprise Value/EBIT (TTM)
-0.26
-1.26
-0.09
Dividends and Shares
BTTX
Low
2-Year Historical Range
BTTX
Average
High
Shares Outstanding
38.50M
19.69M
38.50M
Dividend Per Share (Most Recent)
--
--
--
Dividend Per Share (TTM)
--
--
--
Dividend Yield (TTM)
--
--
--
Payout Ratio (TTM)
--
--
--
Price History
BTTX
Low
2-Year Historical Range
BTTX
Average
High
Beta
46.73
< 0.00
> 50.00
1-Month Total Return
100.00%
< 100.00%
> 1,250.00%
3-Month Total Return
100.00%
< 100.00%
> 670.00%
6-Month Total Return
100.00%
-99.99%
> 100.00%
Year to Date Total Return
100.00%
-100.00%
> 100.00%
1-Year Total Return
-99.55%
-100.00%
> -40.00%
2-Year Total Return
-99.98%
-100.00%
-85.33%
3-Year Total Return
-99.99%
-100.00%
-97.85%
5-Year Total Return
--
--
--
Profitability
BTTX
Low
2-Year Historical Range
BTTX
Average
High
Operating Margin (TTM)
--
--
--
Profit Margin (TTM)
--
--
--
Management Effectiveness
BTTX
Low
2-Year Historical Range
BTTX
Average
High
Return on Assets (TTM)
-95.05%
-134.00%
-64.72%
Return on Equity (TTM)
--
--
--
Income Statement
BTTX
Low
2-Year Historical Range
BTTX
Average
High
Revenue (TTM)
--
--
--
Total Revenue (TTM)
--
--
--
Total Revenue Growth (Q YOY)
--
--
--
Revenue Per Share (TTM)
--
0.00
0.00
Gross Profit (TTM)
--
--
--
EBITDA (TTM)
-27.21M
-40.01M
-27.21M
EBIT (TTM)
-29.61M
-42.04M
-29.61M
Net Income (TTM)
-31.57M
-45.94M
-31.57M
Net Income Avl. to Common (TTM)
-31.57M
-45.94M
-31.57M
Earnings Growth (Q YOY)
48.60%
< 10.00%
48.60%
EPS Diluted (TTM)
-1.16
-3.22
-1.16
EPS Diluted Growth (Q YOY)
68.36%
< 20.00%
68.36%
Balance Sheet
BTTX
Low
2-Year Historical Range
BTTX
Average
High
Cash and Short-Term Inv. (Q)
6.60M
6.07M
> 40.00M
Cash Per Share (Q)
0.17
0.17
2.06
Total Current Assets (Q)
7.35M
7.35M
45.25M
Total Assets (Q)
10.72M
10.72M
50.96M
Total Current Liabilities (Q)
12.94M
3.57M
13.87M
Total Debt (Q)
14.31M
9.51M
14.88M
Total Liabilities (Q)
20.66M
12.87M
23.84M
Total Common Equity (Q)
-9.94M
< -10.00M
> 20.00M
Total Preferred Equity (Q)
--
--
--
Total Equity (Q)
-9.94M
< -10.00M
> 20.00M
Current Ratio (Q)
0.568
0.535
9.862
Book Value Per Share (Q)
-0.24
-0.41
1.56
Cash Flow
BTTX
Low
2-Year Historical Range
BTTX
Average
High
Cash from Operations (TTM)
-26.08M
-38.44M
-26.08M
Cash from Investing (TTM)
-1.32M
-1.76M
-528.00K
Cash from Financing (TTM)
11.69M
< 10.00M
72.33M
Net Change in Cash (TTM)
-15.71M
< -20.00M
> 10.00M
Levered Free Cash Flow (TTM)
-16.45M
-22.39M
-16.06M
TTM - Trailing twelve months. Q - Most recent quarter. YOY - Year over year.
Weiss Ratings